Evidence map›Paper›PMID 41049569›Full record

ArticleJHLT open2025

A structured institutional framework for establishing a living allogenic valve transplant program.

Muhammad Faateh, Muhammad Aanish Raees, Yacmet Colón Berríos, Amra Zekic, Hosam F Ahmed, Tara Karamlou, James F Cnota, Benjamin S Mantell, David L S Morales, Awais Ashfaq

Abstract read
In one paragraph

Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Muhammad FaatehThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Muhammad Aanish RaeesThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Yacmet Colón BerríosThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Amra ZekicThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Hosam F AhmedThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Tara KaramlouThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
James F CnotaThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Benjamin S MantellThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
David L S MoralesThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Awais AshfaqThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Living allogenic valve transplantation (LAVT) refers to transplantation of viable human heart valves in an orthotopic or heterotopic fashion and has recently garnered significant interest for children in need of a living, growing, regenerating valve replacement option. However, at present, there is no standardized approach for establishing and implementing such a program. We provide a practical, step-by-step blueprint of the operational, administrative and regulatory requirements needed to establish an LAVT program based on our center's experience.

Indexed as

Congenital heart diseasePediatric Heart TransplantationValve transplantationValvular heart disease

Identifiers

PMID41049569
PMCPMC12489827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.